Mayo Stephen
- SEC CIK
- 0001849061
In the past year, 1 open-market sale filing worth $123.2K and no purchases.
Current role at each company
- ALLO Allogene Therapeutics, Inc.Directoras of Jun 23, 2026
- SRPT Sarepta Therapeutics, Inc.Directoras of Jun 5, 2026
- MRK Merck & Co., Inc.Directoras of Jun 2, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $123.2K
- 1 filing
- Net
- −$123.2K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Mayo Stephen as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
SRPT Sarepta Therapeutics, Inc.
Director3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 21, 2022 (view filing) | Nov 17 | 4 days | Mayo StephenDirector | SSale | −858 | $109.92 | −$94.3K | −11.8%6.39K after | |
| Mar 6, 2024 (view filing) | Mar 5 | 1 day | Mayo StephenDirector | SSale | −3.13K | $122.96 | −$385.5K | −32.1%6.62K after | |
| Mar 13, 2026 (view filing) | Mar 12 | 1 day | Mayo StephenDirector | SSale | −7.24K | $17.02 | −$123.2K | −80.4%1.76K after |
ALLO Allogene Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 9, 2023 (view filing) | Aug 7 | 2 days | Mayo StephenDirector | SSale | −10.0K | $4.29 | −$42.9K | −28.3%25.3K after |